Development of Caco-2 cells expressing four CYPs via a mammalian artificial chromosome

[1]  K. Harada,et al.  Efficient Generation of Small Intestinal Epithelial-like Cells from Human iPSCs for Drug Absorption and Metabolism Studies , 2018, Stem cell reports.

[2]  Yoshihiro Nakajima,et al.  Human and mouse artificial chromosome technologies for studies of pharmacokinetics and toxicokinetics. , 2018, Drug metabolism and pharmacokinetics.

[3]  D. Satoh,et al.  Establishment of a novel hepatocyte model that expresses four cytochrome P450 genes stably via mammalian-derived artificial chromosome for pharmacokinetics and toxicity studies , 2017, PloS one.

[4]  M. Oshimura,et al.  Development of Caco-2 cells co-expressing CYP3A4 and NADPH-cytochrome P450 reductase using a human artificial chromosome for the prediction of intestinal extraction ratio of CYP3A4 substrates. , 2017, Drug metabolism and pharmacokinetics.

[5]  Kayoko Ohura,et al.  Establishment and Characterization of a Novel Caco-2 Subclone with a Similar Low Expression Level of Human Carboxylesterase 1 to Human Small Intestine , 2016, Drug Metabolism and Disposition.

[6]  Qing-Yu Zhang,et al.  An update on the role of intestinal cytochrome P450 enzymes in drug disposition , 2016, Acta pharmaceutica Sinica. B.

[7]  J. Hakkarainen,et al.  Genetically Modified Caco-2 Cells With Improved Cytochrome P450 Metabolic Capacity. , 2016, Journal of pharmaceutical sciences.

[8]  M. Oshimura,et al.  A pathway from chromosome transfer to engineering resulting in human and mouse artificial chromosomes for a variety of applications to bio-medical challenges , 2015, Chromosome Research.

[9]  M. Oshimura,et al.  A novel and stable mouse artificial chromosome vector. , 2014, ACS synthetic biology.

[10]  V. Dohnal,et al.  Metabolism of aflatoxins: key enzymes and interindividual as well as interspecies differences , 2014, Archives of Toxicology.

[11]  M. Oshimura,et al.  Highly stable maintenance of a mouse artificial chromosome in human cells and mice. , 2013, Biochemical and biophysical research communications.

[12]  Y. Sakaki,et al.  Refined human artificial chromosome vectors for gene therapy and animal transgenesis , 2010, Gene Therapy.

[13]  R. Shipman,et al.  Up-Regulation of Transporters and Enzymes by the Vitamin D Receptor Ligands, 1α,25-Dihydroxyvitamin D3 and Vitamin D Analogs, in the Caco-2 Cell Monolayer , 2009, Journal of Pharmacology and Experimental Therapeutics.

[14]  O. Pelkonen,et al.  Metabolic and Efflux Properties of Caco-2 Cells Stably Transfected with Nuclear Receptors , 2006, Pharmaceutical Research.

[15]  A. Rettie,et al.  THE HUMAN INTESTINAL CYTOCHROME P450 “PIE” , 2006, Drug Metabolism and Disposition.

[16]  M. Reinisalo,et al.  Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[17]  L. Mangravite,et al.  Characterizing the Expression of CYP3A4 and Efflux Transporters (P-gp, MRP1, and MRP2) in CYP3A4-Transfected Caco-2 Cells After Induction with Sodium Butyrate and the Phorbol Ester 12-O-Tetradecanoylphorbol-13-Acetate , 2001, Pharmaceutical Research.

[18]  Shiew-Mei Huang,et al.  Transport and Metabolic Characterization of Caco-2 Cells Expressing CYP3A4 and CYP3A4 Plus Oxidoreductase , 1999, Pharmaceutical Research.

[19]  M. Oshimura,et al.  Functional expression and germline atransmission of a human chromosome fragment in chimaeric mice , 1997, Nature Genetics.

[20]  P. Watkins,et al.  Expression of enzymatically active CYP3A4 by Caco-2 cells grown on extracellular matrix-coated permeable supports in the presence of 1alpha,25-dihydroxyvitamin D3. , 1997, Molecular pharmacology.

[21]  Leslie Z. Benet,et al.  Intestinal drug metabolism and antitransport processes : A potential paradigm shift in oral drug delivery , 1996 .

[22]  M. Oshimura,et al.  Suggestive evidence for functionally distinct, tumor-suppressor genes on chromosomes 1 and 11 for a human fibrosarcoma cell line, HT1080. , 1990, Oncogene.

[23]  A. Stammati,et al.  The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics , 2005, Cell Biology and Toxicology.

[24]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..